These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1977666

  • 21. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
    Inoue M, Shimizu C, Sasagawa T, Shimizu H, Saito J, Tanizawa O.
    Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
    [Abstract] [Full Text] [Related]

  • 22. Differential diagnosis of ovarian cancer, benign ovarian tumor and endometriosis by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels.
    Iwanari O, Miyako J, Date Y, Nakayama S, Kijima S, Moriyama M, Takahashi K, Yoshino N, Karino K, Endoh J.
    Gynecol Obstet Invest; 1990 Jan; 29(1):71-4. PubMed ID: 1972127
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
    Scambia G, Benedetti Panici P, Perrone L, Sonsini C, Giannelli S, Gallo A, Natali PG, Mancuso S.
    Br J Cancer; 1990 Jul; 62(1):147-51. PubMed ID: 2167724
    [Abstract] [Full Text] [Related]

  • 24. [Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers].
    Kawakami H, Sawabu N, Takemori Y, Okai T, Motoo Y, Satomura Y, Ohta H, Watanabe H, Matsuda N, Yamakawa O.
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1141-8. PubMed ID: 2571740
    [Abstract] [Full Text] [Related]

  • 25. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1994 May; 14(6B):2743-6. PubMed ID: 7532929
    [Abstract] [Full Text] [Related]

  • 26. [Expression of blood group-related antigens Lewis A, Lewis B, CA 19-9, and sialyl SSEA-1 in normal human skin in comparison with the patient's blood type].
    Hirai S, Kageshita T, Nakamura T, Yoshii A, Kimura T, Arao T.
    Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):115-20. PubMed ID: 1677054
    [Abstract] [Full Text] [Related]

  • 27. Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells.
    Ohmori K, Yoneda T, Ishihara G, Shigeta K, Hirashima K, Kanai M, Itai S, Sasaoki T, Arii S, Arita H.
    Blood; 1989 Jul; 74(1):255-61. PubMed ID: 2568858
    [Abstract] [Full Text] [Related]

  • 28. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
    Kobayashi H, Terao T, Kawashima Y.
    J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
    [Abstract] [Full Text] [Related]

  • 29. [Clinical usefulness of tumor markers associated with pancreatic cancer].
    Watanabe H, Kawakami H, Yamakawa O, Satomura Y, Ohta H, Motoo Y, Okai T, Sawabu N.
    Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
    [Abstract] [Full Text] [Related]

  • 30. Elevation of sialyl stage-specific mouse embryonic antigen levels in pleural effusion in patients with adenocarcinoma of the lung.
    Iguchi H, Hara N, Miyazaki K, Ohtsu Y, Sonoda F, Ohta M.
    Cancer; 1989 Apr 01; 63(7):1327-30. PubMed ID: 2563956
    [Abstract] [Full Text] [Related]

  • 31. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
    Satoh H, Yano H, Naitoh T, Takahashi N, Suyama T, Murayama J, Kameyama M, Fukuda K, Satoh T, Ohtsuka M.
    Gan To Kagaku Ryoho; 1988 Oct 01; 15(10):2917-22. PubMed ID: 2902833
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
    Kawa S, Kato M, Oguchi H, Hsue GL, Kobayashi T, Koiwai T, Tokoo M, Furuta S, Ichikawa T, Kanai M.
    Scand J Gastroenterol; 1992 Aug 01; 27(8):635-43. PubMed ID: 1359630
    [Abstract] [Full Text] [Related]

  • 37. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M, Ogawa H, Nakanishi K, Tanizawa O, Karino K, Endo J.
    Obstet Gynecol; 1990 Jun 01; 75(6):1032-6. PubMed ID: 2342728
    [Abstract] [Full Text] [Related]

  • 38. Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma.
    Ogawa H, Ghazizadeh M, Araki T.
    Gynecol Obstet Invest; 1996 Jun 01; 41(4):278-83. PubMed ID: 8793500
    [Abstract] [Full Text] [Related]

  • 39. [Serum sialyl Tn antigen as a prognostic marker in patients with epithelial ovarian cancer].
    Kobayashi H, Terao T, Kawashima Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan 01; 44(1):14-20. PubMed ID: 1541859
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.
    Onetto M, Bruzzone M, Conte PF, Ruvolo M, Conio A, Chiara S, Falcone A, Bentivoglio G, Serra GE, Paganuzzi M.
    Oncology; 1989 Jan 01; 46(2):117-22. PubMed ID: 2710476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.